Here is the latest stock price and chart of Aurobindo Pharma. For more details, see the Aurobindo Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
FREE Subscription: Join Our YouTube Channel Today
Live BSE Quotes | Mar 1, 2021 03:36:00 PM | ||
---|---|---|---|
Price (Rs)874.50 | Open (Rs) 868.90 | High (Rs) 878.00 | Low (Rs) 849.45 |
% Change2.29 | Volume 231,112 | Value (Rs) 202,107,444 | 52-Week H/L 1,023.10 / 281.15 |
Live NSE Quotes | Mar 1, 2021 3:29:59 PM | ||
---|---|---|---|
Price (Rs)876.90 | Open (Rs) 855.10 | High (Rs) 879.00 | Low (Rs) 849.40 |
% Change2.54 | Volume 1,653,188 | Value (Rs) 1,428,437,091 | 52-Week H/L 1,023.70 / 288.85 |
Change | |||||
---|---|---|---|---|---|
1 Day 2.29% | 1 Month -5.17% | 3 Months -2.54% | 1 Year 76.72% | 5 Years (CAGR)* 5.17% | 10 Years (CAGR)* 25.34% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 51.38 | P/E Ratio (x) 17.02 | Market Cap (Rs m) 511,730.29 | P/BV (x) 3.68 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
![]() |
||
S&P BSE SENSEX ![]() |
||||||
PERIOD |
AUROBINDO PHARMA last traded price was up 2.3% to Rs 874.5 on the BSE. On the NSE, AUROBINDO PHARMA last traded price was up 2.5% to Rs 876.9. The total volume of shares traded was 1.9 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 1.3%. And the benchmark S&P BSE SENSEX was at 49,849.8 (up 1.5%).
Over the last 30 days, the AUROBINDO PHARMA share price is down 12.4%. And over the last one year, AUROBINDO PHARMA share price is up 73.5%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.
For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.
For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.
Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
A look at what India's top equity mutual funds bought and sold in January 2021.
Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
In this video, I'll show you how to get started on the path to daily trading profits.
More